News
5h
TipRanks on MSNAkero Therapeutics’ Phase 3 NASH Study: A Potential Game-Changer?
Akero Therapeutics (($AKRO)) announced an update on their ongoing clinical study. Akero Therapeutics is conducting a Phase 3 study titled A Phase ...
Individual brings two decades of industry experience to his new role, and has also previously worked at Refinitiv, Bloomberg ...
A new Equifax Canada report shows 1.4 million Canadians missed a credit payment in the second quarter. While that’s up by 118 ...
Manitoba’s near-top position likely results from its relatively low numbers, noted Rebecca Oakes, Equifax Canada vice-president of advanced analytics. The credit reporting agency tracked an average ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results